These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7370532)

  • 21. Intestinal absorption of calcium-47 after treatment with oral oestrogen-gestogens in senile osteoporosis.
    Caniggia A; Gennari C; Borrello G; Bencini M; Cesari L; Poggi C; Escobar S
    Br Med J; 1970 Oct; 4(5726):30-2. PubMed ID: 5470432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
    Ringe JD; Faber H; Fahramand P; Schacht E
    J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
    Gallagher JC; Riggs BL; DeLuca HF
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of different vitamin D treatments on serum vitamin D levels in early postmenopausal women.
    Riis B; Christiansen C; Rodbro P
    Acta Vitaminol Enzymol; 1984; 6(2):77-82. PubMed ID: 6093487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical effects of calcium supplementation in postmenopausal osteoporosis.
    Horowitz M; Need AG; Morris HA; Wishart J; Nordin BE
    Eur J Clin Nutr; 1988 Sep; 42(9):775-8. PubMed ID: 3181110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.
    Gillespie WJ; Henry DA; O'Connell DL; Robertson J
    Cochrane Database Syst Rev; 2000; (2):CD000227. PubMed ID: 10796331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local action of oral 1,25-dihydroxycholecalciferol on calcium absorption in osteoporosis.
    Francis RM; Peacock M
    Am J Clin Nutr; 1987 Aug; 46(2):315-8. PubMed ID: 3618534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale for active vitamin D and analogs in the treatment of osteoporosis.
    Nishii Y
    J Cell Biochem; 2003 Feb; 88(2):381-6. PubMed ID: 12520540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The suitability of 1-alpha-hydroxycholecalciferol for the prevention of recurrent parturient paresis in dairy cows].
    Zepperitz H
    Tierarztl Prax; 1993 Feb; 21(1):19-25. PubMed ID: 8470100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does oestriol add to the beneficial effect of combined hormonal prophylaxis against early postmenopausal osteoporosis?
    Christiansen C; Rødbro P
    Br J Obstet Gynaecol; 1984 May; 91(5):489-93. PubMed ID: 6722065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D and bone health in postmenopausal women.
    Malabanan AO; Holick MF
    J Womens Health (Larchmt); 2003 Mar; 12(2):151-6. PubMed ID: 12737713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.
    Riggs BL; Seeman E; Hodgson SF; Taves DR; O'Fallon WM
    N Engl J Med; 1982 Feb; 306(8):446-50. PubMed ID: 6276746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of adherence to osteoporosis treatment in clinical practice.
    Rossini M; Bianchi G; Di Munno O; Giannini S; Minisola S; Sinigaglia L; Adami S;
    Osteoporos Int; 2006; 17(6):914-21. PubMed ID: 16538553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
    Christiansen C; Riis BJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):836-41. PubMed ID: 2205624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of vitamin D. A comparison of 1 alpha OHD2 and 1 alpha OHD3 in rats.
    Sjödén G
    Acta Orthop Scand Suppl; 1985; 217():1-84. PubMed ID: 3911723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical study on combination of multiple regimens in treatment of osteoporosis in perimenopause and postmenopausal women].
    Guan YT; Cai LL; Ding HX; Chen GD; Hu Y
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):571-4. PubMed ID: 21029610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does calcium potentiate the bone-preserving effect of oestrogen treatment in early post-menopausal women by a change in vitamin D metabolism?
    Riis BJ; Christiansen C
    Maturitas; 1984 Jul; 6(1):65-70. PubMed ID: 6381968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age of menopause and fracture risk in postmenopausal women randomized to calcium + vitamin D, hormone therapy, or the combination: results from the Women's Health Initiative Clinical Trials.
    Sullivan SD; Lehman A; Nathan NK; Thomson CA; Howard BV
    Menopause; 2017 Apr; 24(4):371-378. PubMed ID: 27801706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.